Related Experiment Videos
One-step, labeled-antibody assay for measuring free thyroxin. I. Assay development and validation
N D Christofides1, C P Sheehan, J E Midgley
1Amerlite Diagnostics Ltd., Cardiff Laboratories, Whitchurch, U.K.
Clinical Chemistry
|January 1, 1992
Summary
A new radioassay accurately measures free thyroxin (FT4) in serum. This method uses magnetizable particles and labeled antibodies for efficient and valid FT4 quantification.
Area of Science:
- Endocrinology
- Immunoassay Development
- Radiochemistry
Background:
- Accurate measurement of free thyroxin (FT4) is crucial for diagnosing thyroid disorders.
- Existing immunoassays may have limitations in speed or specificity.
Purpose of the Study:
- To develop and validate a novel, one-step radioassay for quantifying free thyroxin (FT4) in biological samples.
- To introduce a new principle for FT4 measurement using magnetizable particles.
Main Methods:
- A one-step radioimmunoassay was developed utilizing magnetizable polymer particles coupled with L-triiodothyronine (T3).
- 125I-labeled monoclonal anti-thyroxin antibodies were employed, with FT4 competing against T3 for antibody binding.
- Radioactivity bound to the solid phase was measured and correlated with FT4 concentration.
Main Results:
- The assay demonstrated technical validity for measuring free thyroxin (FT4) in serum and plasma.
- The principle relies on the competitive binding of FT4 and T3 to labeled antibodies.
Conclusions:
- A novel, one-step radioassay for FT4 measurement has been successfully developed.
- This method offers a potentially efficient and valid approach for FT4 quantification in clinical settings.